Focal laser thermocoagulation for localized prostate cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Focal therapy involving destruction of prostate specific region containing a clinically meaningful tumor is a new treatment for prostate cancer. Despite the absence of long-term results of applying this method of treatment, there are prerequisites that allow to consider focal therapy as a method with a lower risk of side effects typical of conventional treatment. Focal laser thermocoagulation is a developing technique with a number of advantages, the most important of which is the ability to perform the treatment under the real-time magnetic resonance imaging control. This review describes the principles of laser thermocoagulation, and presents the data of already published clinical studies, as well as the eligibility criteria for focal laser thermocoagulation of prostate cancer. The prospects of development of the method are discussed.

Full Text

Restricted Access

About the authors

P. V Glybochko

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: rektorat@mma.ru
Department and Clinic of Urology

A. Z Vinarov

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: avinarov@mail.ru
Department and Clinic of Urology

E. V Shpot

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: nisorokin@mail.ru
Department and Clinic of Urology

N. I Sorokin

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: nisorokin@mail.ru
Department and Clinic of Urology

A. M Dymov

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: alimdv@mail.ru
Clinic of Urology

D. V Chinenov

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: chinenovdv@rambler.ru
Department and Clinic of Urology

D. V Enikeev

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: enikeev_dv@mail.ru
Department and Clinic of Urology

E. A Shmeleva

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: evgeniya_shmeleva94@mail.ru
Department and Clinic of Urology

A. V Koshkarev

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: koshkarevalexey@gmail.com
Department and Clinic of Urology

I. S Lumpov

First MSMU n.a. I.M. Sechenov; SRI of Uronephrology and Human Reproductive Health

Email: ilushkin_doc@mail.ru
Department and Clinic of Urology

References

  1. Shibata A., Ma J., Whittemore A.S. Prostate cancer incidence and mortality in the United States and the United Kingdom. J. Natl Cancer Inst. 1998;90:1230-1231.
  2. Loeb S., Bjurlin M.A., Nicholson J. et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65:1046-1055.
  3. Sanda M.G., Dunn R.L., Michalski J. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl J. Med. 2008; 358:1250-1261.
  4. Litwin M.S., Hays R.D., Fink A. et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-135.
  5. Bill-Axelson A., Holmberg L., Garmo H. et al. Radical prostatectomy or watchful waiting in early prostate cancer. N. Engl J. Med. 2014;370:932-942.
  6. Cooperberg M.R., Carroll P.R., Klotz L. Active surveillance for prostate cancer: progress and promise. J. Clin Oncol. 2011;29:3669-3676.
  7. Lindner U., Lawrentschuk N., Schatloff O., Trachtenberg J., Lindner A. Evolution from active surveillance to focal therapy in the management of prostate cancer. J. Urol. 2012;2012:589160.
  8. Bahn D., de Castro Abreu A.L., Gill I.S. et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62:55-63.
  9. Ahmed H.U., Moore C., Emberton M. Minimallyinvasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol. 2009;18:219-232.
  10. Arumainayagam N., Moore C.M., Ahmed H.U., Emberton M. Photodynamic therapy for focal ablation of the prostate. World J. Urol. 2010;28:571-576.
  11. Oto A., Sethi I., Karczmar G., et al. MR imaging-guided focal laser ablation for prostate cancer: phase I. trial. Radiology. 2013;267:932-940.
  12. Colin P., Mordon S., Nevoux P., et al. Focal laser ablation of prostate cancer: definition, needs, and future. Adv Urol. 2012;2012:589160.
  13. Stafford R.J., Shetty A., Elliott A.M. et al. Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J. Urol. 2010;184:1514-1520.
  14. Lindner U., Lawrentschuk N., Weersink R.A. et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 10;57:1111-1114.
  15. Lindner U., Lawrentschuk N., Trachtenberg J. Focal laser ablation for localized prostate cancer. J. Endourol. 2010;24:791-797. Eur Urol. 2010; 58(1):173-177.
  16. Cepek J., Lindner U., Ghai S., Louis A.S., Davidson S.R., Gertner M., Hlasny E., Sussman M.S., Fenster A., Trachtenberg J. Mechatronic system for in-bore MRI-guided insertion of needles to the prostate: An in vivo needle guidance accuracy study. J. Magn Reson Imaging. 2015;42(1):48-55.
  17. Lijens G.J., Huisman H.J., Elliott R.M., Shih N.N., Feldman M.D., Viswanath S., Fütterer J.J., Bomers J.G., Madabhushi A. Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy. Eur Urol. 2010;58(1):173-177.
  18. Viswanath S., Toth R., Rusu M., Sperling D., Lepor H., Futterer J., Madabhushi A. Identifying Quantitative In Vivo Multi-Parametric MRI Features For Treatment Related Changes after Laser Interstitial Thermal Therapy of Prostate Cancer. Eur Urol. 2015;68(6):924-926.
  19. Viswanath S., Toth R., Rusu M., Sperling D., Lepor H., Futterer J., Madabhushi A. Quantitative Evaluation of Treatment Related Changes on Multi-Parametric MRI after Laser Interstitial Thermal Therapy ofProstate Cancer. Urol J. 2014;11(4):1788-1792.
  20. Feng Y., Fuentes D. Model-based planning and real-time predictive control for laser-induced thermal therapy. Int J. Hyperthermia. 2011;27(8): 751-761.
  21. Woodrum D.A., Mynderse L.A., Gorny K.R., Amrami K.K., McNichols R.J., Callstrom M.R. 3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. BJU Int. 2012;109(3):452-458.
  22. Woodrum D.A., Gorny K.R., Mynderse L.A., Amrami K.K., Felmlee J.P., Bjarnason H., Garcia-Medina O.I., McNichols R.J., Atwell T.D., Callstrom M.R. Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. Future Oncol. 2011;7(6):775-787.
  23. Peters R.D., Chan E., Trachtenberg J. et al. Magnetic resonance thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine prostate model. Magn Reson Med. 2000;44:873-883.
  24. van Nimwegen S.A., L’Eplattenier H.F., Rem A.I. et al. Nd:YAG surgical laser effects in canine prostate tissue: temperature and damage distribution. Phys Med Biol. 2009;54:29-44
  25. Colin P., Nevoux P., Marqa M., Auger F., Leroy X., Villers A., Puech P., Mordon S., Betrouni N. Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour. Comput Methods Programs Biomed. 2012;108(1): 213-223
  26. Кочиев Д.Г., Голубева А., Иванов А.В., Зонтов С.В., Кожин О.К., Лукин А.В., Ротин Д.Л., Теодорович О.В. Интерстициальная лазерная коагуляция как метод лечения локализованных опухолей почки и предстательной железы: результаты экспериментов in vivo. Альманах клинической медицины. 2006;12(76):61
  27. Теодорович О.В., Теплов А.А., Андреева Ю.Ю., Богославский А.В., Борисенко Г.Г., Нарышкин С.А., Кочиев Д.Г. Внутритканевая лазерная коагуляция предстательной железы. Онкохирургия. 2012;4(1):55-60
  28. Расщупкина Е.В., Теодорови О.В., Кочиев Д.Г., Андреева Ю.Ю., Шатохин М.Н., Борисенко Г.Г., Нарышкин С.А., Абдуллаев М.И. Экспериментальное обоснование использования ND:YAG-лазерной коагуляции ткани предстательной железы. Медицинский вестник Башкортостана. 2015;10(3):616.65_002-089.87
  29. Huong G.T., Wang T.H., Sheu J.C. et al. Lowpower laserthermia for the treatment of small hepatocellular carcinoma. Eur J Cancer. 1991;27: 1622-1627.
  30. Marqa M.F., Colin P., Nevoux P., Mordon S.R., Betrouni N. Focal laser ablation of prostate cancer: numerical simulation of temperature and damage distribution. 2011;22(7):929-934.
  31. Rieke V., Vigen K.K., Sommer G. et al. Referenceless PRF shift thermometry. Magn Reson Med. 2004;51:1223-1231.
  32. Amin Z., Wenger C.W.R., Bown S.G. Technical note: interstitial laser photocoagulation for the treatment of prostatic cancer. Br J Radiol. 1993;66:1044-1047.
  33. Atri M., Gertner M.R., Haider M.A. et al. Contrastenhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. Can Urol Assoc J. 2009; 3:125-130.
  34. Lindner U., Weersink R.A., Haider M.A. et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol. 2009;182: 1371-1377.
  35. Raz O., Haider M.A., Davidson S.T. et al. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol. 2010;58:173-177.
  36. Lindner G., Horland R., Wagner I. et al. De novo formation and ultra-structural characterization of a fiber-producing human hair follicle equivalent in vitro. J Biotechnol. 2011;152:108-112.
  37. Lee T., Mendhiratta N., Sperling D., Lepor H. Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. Rev Urol. 2014;16(2):55-66.
  38. Lepor H., Llukani E., Sperling D., Fütterer J.J. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer. Eur Urol. 2015;68:924-926.
  39. Natarajan S., Raman S., Priester A.M., Garritano J., Margolis D.J., Lieu P., Macairan M.L., Huang J., Grundfest W., Marks L.S. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. J Urol. 2015 pii: S0022-5347(15)05540-8.
  40. Wenger H., Yousuf A., Oto A., Eggener S. Laser ablation as focal therapy for prostate cancer. Curr Opin Urol. 2014;24(3):236-240.
  41. Woodrum D.A., Mynderse L.A., Gorney K.R., et al. 3.0 T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol. 2011;22:929-934.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies